Popular weight-loss drugs are meant to be lifelong medications treating a disease, not lifestyle fixes.

Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Anything that helps Americans lose weight, reduces treatment barriers and makes care more affordable should be welcomed. But ...

Canadian Prime Minister Mark Carney will visit Australia in March. Prime Minister Anthony Albanese confirmed the visit and ...

The Place of Tides chronicles a spring season in the remote Vega archipelago in Norway, just south of the Arctic Circle. The ...

As Ozempic reshapes bodies and expectations, a new book probes the science, profits and risks behind the global weight-loss boom ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

France's government has weathered two no-confidence votes in parliament. This follows a decision to push through budget ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, ...